Aspiriant LLC’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2M Sell
29,094
-2,367
-8% -$359K 0.12% 77
2025
Q4
$4.51M Buy
31,461
+97
+0.3% +$14.3K 0.13% 74
2025
Q3
$4.82M Sell
31,364
-1,160
-4% -$181K 0.15% 65
2025
Q2
$5.18M Buy
32,524
+237
+0.7% +$38.7K 0.16% 62
2025
Q1
$5.5M Sell
32,287
-789
-2% -$132K 0.19% 54
2024
Q4
$5.55M Buy
33,076
+2,510
+8% +$427K 0.2% 55
2024
Q3
$5.29M Buy
30,566
+1,743
+6% +$296K 0.2% 54
2024
Q2
$4.75M Sell
28,823
-1,616
-5% -$264K 0.19% 56
2024
Q1
$4.94M Sell
30,439
-210
-0.7% -$32.9K 0.2% 57
2023
Q4
$4.49M Buy
30,649
+105
+0.3% +$15.6K 0.2% 57
2023
Q3
$4.46M Buy
30,544
+308
+1% +$47K 0.23% 55
2023
Q2
$4.59M Buy
30,236
+91
+0.3% +$13.7K 0.23% 53
2023
Q1
$4.48M Sell
30,145
-855
-3% -$122K 0.23% 54
2022
Q4
$4.7M Buy
31,000
+862
+3% +$121K 0.24% 52
2022
Q3
$3.81M Buy
30,138
+277
+0.9% +$39.3K 0.19% 59
2022
Q2
$4.29M Sell
29,861
-1,133
-4% -$170K 0.21% 55
2022
Q1
$4.74M Sell
30,994
-928
-3% -$145K 0.26% 52
2021
Q4
$5.22M Buy
31,922
+10,193
+47% +$1.51M 0.28% 47
2021
Q3
$3.04M Sell
21,729
-2,304
-10% -$327K 0.18% 59
2021
Q2
$3.24M Sell
24,033
-3,952
-14% -$535K 0.18% 56
2021
Q1
$3.79M Buy
27,985
+5,752
+26% +$750K 0.24% 41
2020
Q4
$3.09M Sell
22,233
-35,783
-62% -$5M 0.21% 47
2020
Q3
$8.06M Buy
58,016
+35,587
+159% +$4.72M 0.63% 25
2020
Q2
$2.68M Sell
22,429
-20,048
-47% -$2.34M 0.25% 47
2020
Q1
$4.67M Buy
42,477
+19,108
+82% +$2.29M 0.46% 32
2019
Q4
$2.92M Sell
23,369
-167
-0.7% -$20.4K 0.27% 47
2019
Q3
$2.92M Sell
23,536
-20,779
-47% -$2.46M 0.26% 58
2019
Q2
$4.86M Buy
44,315
+3,613
+9% +$385K 0.41% 45
2019
Q1
$4.23M Sell
40,702
-256
-0.6% -$24.9K 0.35% 48
2018
Q4
$3.77M Sell
40,958
-1,103
-3% -$98.6K 0.29% 53
2018
Q3
$3.5M Sell
42,061
-27,150
-39% -$2.22M 0.3% 56
2018
Q2
$5.4M Buy
69,211
+3,240
+5% +$244K 0.46% 46
2018
Q1
$5.23M Buy
65,971
+61,093
+1,252% +$5.09M 0.46% 45
2017
Q4
$448K Sell
4,878
-67,938
-93% -$6.11M 0.13% 54
2017
Q3
$6.63M Sell
72,816
-5,891
-7% -$536K 0.56% 37
2017
Q2
$6.86M Buy
78,707
+26,965
+52% +$2.38M 0.6% 34
2017
Q1
$4.65M Sell
51,742
-21,204
-29% -$1.88M 0.4% 43
2016
Q4
$6.13M Buy
72,946
+13,279
+22% +$1.13M 0.56% 28
2016
Q3
$5.36M Sell
59,667
-370
-0.6% -$32.1K 0.53% 29
2016
Q2
$4.97M Sell
60,037
-6,222
-9% -$511K 0.47% 37
2016
Q1
$5.45M Buy
66,259
+16,786
+34% +$1.35M 0.52% 30
2015
Q4
$3.93M Sell
49,473
-5,452
-10% -$417K 0.43% 26
2015
Q3
$3.95M Sell
54,925
-9,578
-15% -$718K 0.33% 26
2015
Q2
$5.05M Buy
64,503
+146
+0.2% +$11.7K 0.49% 19
2015
Q1
$5.27M Buy
64,357
+48,680
+311% +$4.19M 0.68% 15
2014
Q4
$1.43M Buy
15,677
+2,013
+15% +$177K 0.19% 30
2014
Q3
$1.14M Sell
13,664
-843
-6% -$69.1K 0.16% 29
2014
Q2
$1.14M Buy
14,507
+713
+5% +$57.5K 0.16% 38
2014
Q1
$1.11M Buy
13,794
+15
+0.1% +$1.18K 0.16% 43
2013
Q4
$1.12M Buy
+13,779
New +$1.12M 0.17% 37
2013
Q3
Sell
-13,760
Closed -$1.06M 60
2013
Q2
$1.06M Buy
+13,760
New +$1.08M 0.17% 33

Other funds holding PG

Aspiriant LLC's PG Position: Q1 2026 in Review

Aspiriant LLC reduced its Procter & Gamble (PG) stake by 7.5% in Q1 2026, selling an estimated $359K and leaving 29,094 shares worth $4.2M. The position accounts for 0.12% of the portfolio, ranked #77.

Aspiriant LLC first reported a position in PG in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.06M in Q3 2020. 3,984 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Aspiriant LLC held 29,094 shares of Procter & Gamble worth $4.2M as of Q1 2026.
  • Aspiriant LLC sold 2,367 Procter & Gamble shares in Q1 2026, an estimated $359K.
  • Procter & Gamble made up 0.12% of Aspiriant LLC's portfolio in Q1 2026, its #77 holding.
  • Aspiriant LLC first reported a position in Procter & Gamble in Q2 2013 and has held it in 51 quarters since.
  • Aspiriant LLC's Procter & Gamble position peaked at $8.06M in Q3 2020.
  • 3,984 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.